Click Therapeutics gets FDA authorization for migraine treatment
In a sign of life for the digital therapeutics industry, Click Therapeutics has received FDA authorization for its treatment. The FDA has given marketing authorization for Click’s digital therapeutic to preventively treat episodic migraines, the ...
